A Platform for Controlled Dual‐Drug Delivery to the Retina: Protective Effects against Light‐Induced Retinal Damage in Rats

Controlled transscleral co-delivery of two drugs, edaravone (EDV) and unoprostone (UNO), using a platform that comprises a microfabricated reservoir, controlled-release cover, and drug formulations, which are made of photopolymerized poly(ethyleneglycol) dimethacrylates, shows synergistic retinal neuroprotection against light injury in rats when compared with single-drug-loaded devices. The device would offer a safer therapeutic method than intravitreal injections for retinal disease treatments.

[1]  Yun‐Min Zheng,et al.  ROS-dependent signaling mechanisms for hypoxic Ca(2+) responses in pulmonary artery myocytes. , 2010, Antioxidants & redox signaling.

[2]  R. Feldman,et al.  Efficacy and safety of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure. , 2004, Ophthalmology.

[3]  H. Kaji,et al.  A polymeric device for controlled transscleral multi-drug delivery to the posterior segment of the eye. , 2014, Acta biomaterialia.

[4]  M. Murphy.  Modulating Mitochondrial Intracellular Location as a Redox Signal , 2012, Science Signaling.

[5]  R. Spaide.  RATIONALE FOR COMBINATION THERAPY IN AGE-RELATED MACULAR DEGENERATION , 2009, Retina.

[6]  Jacob D. Feala,et al.  Search Algorithms as a Framework for the Optimization of Drug Combinations , 2008, PLoS Comput. Biol..

[7]  Y Ikada,et al.  Long-term sustained release of ganciclovir from biodegradable scleral implant for the treatment of cytomegalovirus retinitis. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[8]  Jayakrishna Ambati,et al.  Transscleral drug delivery to the retina and choroid , 2002, Progress in Retinal and Eye Research.

[9]  H F Edelhauser,et al.  Transscleral drug delivery for posterior segment disease. , 2001, Advanced drug delivery reviews.

[10]  S. H. Dickens,et al.  Effects of adhesive, base and diluent monomers on water sorption and conversion of experimental resins. , 2010, Dental materials : official publication of the Academy of Dental Materials.

[11]  Michael E. Greenberg,et al.  Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis , 1995, Science.

[12]  H. Kamata,et al.  Redox regulation of cellular signalling. , 1999, Cellular signalling.

[13]  H. Hara,et al.  Systemic administration of a free radical scavenger, edaravone, protects against light-induced photoreceptor degeneration in the mouse retina. , 2010, European journal of pharmacology.

[14]  Li-ping Yang,et al.  Role of NF-kappaB and MAPKs in light-induced photoreceptor apoptosis. , 2007, Investigative ophthalmology & visual science.

[15]  David J. Calkins,et al.  Critical pathogenic events underlying progression of neurodegeneration in glaucoma , 2012, Progress in Retinal and Eye Research.

[16]  Nicholas A Peppas,et al.  Historical perspective on advanced drug delivery: how engineering design and mathematical modeling helped the field mature. , 2013, Advanced drug delivery reviews.

[17]  H. Hara,et al.  Unoprostone reduces oxidative stress- and light-induced retinal cell death, and phagocytotic dysfunction, by activating BK channels , 2011, Molecular vision.

[18]  K. Unoki,et al.  Photoreceptor Protection against Constant Light-Induced Damage by Isopropyl Unoprostone, a Prostaglandin F2α Metabolite-Related Compound , 2001, Ophthalmic Research.

[19]  Kristi S Anseth,et al.  Manipulations in hydrogel degradation behavior enhance osteoblast function and mineralized tissue formation. , 2006, Tissue engineering.

[20]  G. Prestwich,et al.  Stimulation of in vivo angiogenesis by in situ crosslinked, dual growth factor-loaded, glycosaminoglycan hydrogels. , 2010, Biomaterials.

[21]  T. Desai,et al.  Nanostructured thin film polymer devices for constant-rate protein delivery. , 2012, Nano letters.

[22]  R. Sun,et al.  Closed-loop control of cellular functions using combinatory drugs guided by a stochastic search algorithm , 2008, Proceedings of the National Academy of Sciences.

[23]  E. Gragoudas,et al.  Pegaptanib for neovascular age-related macular degeneration. , 2004, The New England journal of medicine.

[24]  Veli-Pekka Ranta,et al.  Transscleral drug delivery to the posterior eye: prospects of pharmacokinetic modeling. , 2006, Advanced drug delivery reviews.

[25]  Mauro Ferrari,et al.  Leveraging nanochannels for universal, zero-order drug delivery in vivo. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[26]  D. DeFranco,et al.  Opposing Roles for ERK1/2 in Neuronal Oxidative Toxicity , 2006, Journal of Biological Chemistry.

[27]  S. Resnikoff,et al.  Global data on visual impairment in the year 2002. , 2004, Bulletin of the World Health Organization.

[28]  J. Cuppoletti,et al.  Cellular and molecular effects of unoprostone as a BK channel activator. , 2007, Biochimica et biophysica acta.

[29]  S. Kalachandra.  Influence of fillers on the water sorption of composites. , 1989, Dental materials : official publication of the Academy of Dental Materials.

[30]  H. Yip,et al.  Combined effect of brain-derived neurotrophic factor and LINGO-1 fusion protein on long-term survival of retinal ganglion cells in chronic glaucoma , 2009, Neuroscience.

[31]  Robert Langer,et al.  Reservoir-based drug delivery systems utilizing microtechnology. , 2012, Advanced drug delivery reviews.